Covered recipient · General Payments record
BETH A DENMON
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$250.51
- Reported across 12 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $210.10 | 10 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $44.03 | 2 |
| Exact Sciences Corporation | $38.27 | 2 |
| Lilly USA, LLC | $26.46 | 1 |
| Abbott Laboratories | $24.35 | 1 |
| Axsome Therapeutics, Inc. | $24.29 | 1 |
| GENZYME CORPORATION | $18.38 | 1 |
| Kowa Pharmaceuticals America, Inc. | $17.59 | 1 |
| Astellas Pharma US Inc | $16.73 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $24.35 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125149458 | CMS |
| Astellas Pharma US Inc | $16.73 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139515447 | CMS |
| Axsome Therapeutics, Inc. | $24.29 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148340785 | CMS |
| Exact Sciences Corporation | $17.74 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114412902 | CMS |
| Exact Sciences Corporation | $20.53 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114412907 | CMS |
| GENZYME CORPORATION | $18.38 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139845789 | CMS |
| Kowa Pharmaceuticals America, Inc. | $17.59 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1113472683 | CMS |
| Lilly USA, LLC | $26.46 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135600677 | CMS |
| Novo Nordisk Inc | $21.89 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100577040 | CMS |
| Novo Nordisk Inc | $22.14 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100413810 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2024
- Source files
- Dataset page · Bulk file · PY2021 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.